Healthcare provider profile · identity verified

Alex Patrick Galloway, MD

Internal Medicine · ATLANTA, GA · NPI 1457810772

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	392	179
Amlodipine Besylate	Amlodipine Besylate	388	163
Gabapentin	Gabapentin	246	109
Ozempic	Semaglutide	215	49
Rosuvastatin Calcium	Rosuvastatin Calcium	199	88
Losartan Potassium	Losartan Potassium	191	84
Albuterol Sulfate Hfa	Albuterol Sulfate	190	59
Lisinopril	Lisinopril	162	70
Hydrochlorothiazide	Hydrochlorothiazide	141	65
Metformin Hcl	Metformin Hcl	121	54
Carvedilol	Carvedilol	120	54
Fluticasone Propionate	Fluticasone Propionate	117	59
Farxiga	Dapagliflozin Propanediol	106	51
Tamsulosin Hcl	Tamsulosin Hcl	99	41
Omeprazole	Omeprazole	93	39
Famotidine	Famotidine	90	38
Levothyroxine Sodium	Levothyroxine Sodium	81	29
Diclofenac Sodium	Diclofenac Sodium	80	31
Duloxetine Hcl	Duloxetine Hcl	80	38
Metoprolol Succinate	Metoprolol Succinate	73	35
Furosemide	Furosemide	72	28
Esomeprazole Magnesium	Esomeprazole Magnesium	69	30
Allopurinol	Allopurinol	62	21
Chlorthalidone	Chlorthalidone	55	18
Ventolin Hfa	Albuterol Sulfate	54	23
Spironolactone	Spironolactone	53	26
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	52	26
Nifedipine Er	Nifedipine	47	20
Symbicort	Budesonide/Formoterol Fumarate	45	18
Pantoprazole Sodium	Pantoprazole Sodium	44	24
Eliquis	Apixaban	43	20
Ezetimibe	Ezetimibe	42	18
Tresiba Flextouch U-100	Insulin Degludec	40	16
Metformin Hcl Er	Metformin Hcl	39	20
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Clopidogrel	Clopidogrel Bisulfate	36	15
Jardiance	Empagliflozin	36	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	19
Pregabalin	Pregabalin	33	18
Clotrimazole	Clotrimazole	32	suppressed
Ketoconazole	Ketoconazole	32	suppressed
Finasteride	Finasteride	31	suppressed
Levetiracetam	Levetiracetam	31	15
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Trulicity	Dulaglutide	29	11
Xarelto	Rivaroxaban	29	12
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Torsemide	Torsemide	27	14
Montelukast Sodium	Montelukast Sodium	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Januvia	Sitagliptin Phosphate	25	12
Valsartan	Valsartan	25	15
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	12
Sertraline Hcl	Sertraline Hcl	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	21	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	11
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	15	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Baclofen	Baclofen	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Colchicine	Colchicine	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error